Back
Oncternal Therapeutics Vs. Eli Lilly and Industry Stock Comparison
Sell
3
ONCT
Oncternal Therapeutics
Last Price:
1.71
Seasonality Move:
5.35%
Sell
47
LLY
Eli Lilly and
Last Price:
915.51
Seasonality Move:
4.48%
Sell
3
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy, Sell or Hold?
- The current Oncternal Therapeutics [ONCT] share price is $1.69. The Score for ONCT is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
- ONCT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $904.97. The Score for LLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ONCT Stock Price Chart
What is Oncternal Therapeutics's stock price today?
-
The Oncternal Therapeutics share price today is $1.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing slight buying pressure.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $904.97
The current trend is relatively stagnant and LLY is experiencing selling pressure, which indicates risk of future bearish movement.
ONCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.95 | Sell |
Relative Strength Index (14 RSI): | 21.44 | Sell |
Chaikin Money Flow: | 52731 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.59 - 4.81) | Sell |
Bollinger Bands (100): | (4.62 - 8.82) | Sell |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.67 | Buy |
Relative Strength Index (14 RSI): | 46.74 | Sell |
Chaikin Money Flow: | -1325849 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (913.47 - 951.51) | Sell |
Bollinger Bands (100): | (797.71 - 929.13) | Buy |
ONCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.52 | Sell |
20-day SMA: | 3.61 | Sell |
50-day SMA: | 5.08 | Sell |
200-day SMA: | 7.77 | Sell |
8-day EMA: | 2.3 | Sell |
20-day EMA: | 3.3 | Sell |
50-day EMA: | 4.73 | Sell |
200-day EMA: | 7.26 | Sell |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 915.48 | Sell |
20-day SMA: | 932.76 | Sell |
50-day SMA: | 895.56 | Buy |
200-day SMA: | 778.51 | Buy |
8-day EMA: | 916.63 | Sell |
20-day EMA: | 918.54 | Sell |
50-day EMA: | 899.91 | Buy |
200-day EMA: | 786.32 | Buy |
Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $1.11 per share, an increase this year of $2.00 per share, and an increase next year of $2.22 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.62 per share, an increase next quarter of $1.15 per share, an increase this year of $10.06 per share, and an increase next year of $6.23 per share.
Oncternal Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |